Podcasts
Podcast: life as a PhD student
Pavel and Kata from our group recorded a podcast about life as a PhD student. The discussion gives a general idea on what pursuing a
June 7, 2022
Catch up on the latest news about what we’ve been up to and what’s happening at Haapaniemi Lab, including new job openings, research updates, new publications and team events.
Menu
All news
Events & Appearances
Our poster from the May 2022 ASGCT conference
Kata presented her work on CRISPR-Cas9 T cell pipeline optimisation at the American Society for Gene and Cell Therapy (ASGCT) conference in Washington D.C. The
May 23, 2022
Research & Publications
Plasmids are now available in Addgene
We’ve now deposited the main plasmids from the following publication by Reint et al. to Addgene for distribution to the research community. Rapid Genome Editing
May 10, 2022
Lab & Team Updates
Celebrating Frida’s Master Thesis
We’ve had a lovely reason to celebrate as one of our alumni, Frida, completed her master thesis recently! She defended her thesis on January 14th,
March 9, 2022
Grants & Funding
We’ve received a 20m grant from the Research Council of Norway
We are very happy to announce that we’ve received a 19.9 million NOK grant from the Research Council of Norway to research personalised gene editing
March 1, 2022
Events & Appearances
Emma presented our research during Bioteknologidagen 2022 Oslo
Emma presented our research at the Biotechnology Day 2022 in Oslo – Gene therapy: present and future
February 17, 2022
Recruitment
[Closed] Senior researcher position in the Haapaniemi group
We’re looking for senior researchers to join our enthusiastic team and work on developing the CRISPR-Cas9 gene editing platform for clinical applications. Please note, this
February 16, 2022
Research & Publications
Rapid genome editing by CRISPR-Cas9-POLD3 fusion
We are delighted to present our newest article, “Rapid genome editing by CRISPR-Cas9-POLD3 fusion”, published in eLife in December 2021. Abstract Precision CRISPR gene editing relies on
February 3, 2022
Grants & Funding
We’ve received an 8m grant from the Norwegian Cancer Society
The Norwegian Cancer Society has granted our lab NOK 7 970 000 for developing CRISPR-Cas gene therapy for blood cancer predisposition syndromes for 2022-2025. The
November 15, 2021
Events & Appearances
Best poster award at the annual CRISPR meeting
Zhuokun Li won the Best Poster Award at the annual CRISPR meeting at the Wellcome Trust Sanger Institute.
October 1, 2021